MIT Horizon spotlights Controlant
In a recent interview with MIT Horizon, Erlingur Brynjúlfsson, Chief Strategy Officer and co-founder, sheds light on how Controlant’s real-time monitoring solutions enable the safe, efficient, and sustainable delivery of medicines and vaccines while eliminating waste and ensuring patient safety.
Erlingur highlights that the “consistent flow of high-quality data“ is key in driving decision-making in pharma supply chains to prevent waste and ensure patient safety.
The article covers Controlant’s role in supporting the delivery of more than 6 billion Covid-19 vaccine doses to global destinations, and the company’s vision of enabling zero-waste pharma supply chains in collaboration with the world’s leading pharmaceutical companies and logistics service providers.
MIT Horizon offers an exclusive library, events, and workshops that provide the continuous learning a global workforce needs to understand and leverage today's innovations.
Read the full case study
